AbbVie Appeals to Supreme Court Over Attorney-Client Privilege in Patent Litigation

Pharmaceutical giant AbbVie is seeking intervention from the U.S. Supreme Court in a contentious discovery dispute, contending that certain communications are protected under attorney-client privilege. The issue stems from a contentious Pennsylvania patent litigation that AbbVie has labeled a “sham.” The company is urging the high court to provide clarity on the matter, which could have far-reaching implications for future patent disputes and the bounds of privileged communications in legal contexts. For more details, visit the original [Law360 article](https://www.law360.com/articles/1857634/abbvie-brings-atty-client-privilege-fight-to-supreme-court).